PepGen is one of several companies vying to bring to market the first treatment for the rare muscle disorder myotonic dystrophy type 1, or DM1. Preliminary Phase 1 data indicate its drug candidate is competitive with others further ahead in development. The post PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With…
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that occurred recently in the healthcare sector. She also interviewed Claire Zangerle, who was appointed as chief nurse executive of the American Hospital Association, as well as CEO of its American Organization for Nursing Leadership. The post MedCity…
SACRAMENTO, Calif. — After decades of unsuccessful efforts to improve California prison conditions ruled unconstitutional and blamed for record-high suicides, advocates and a federal judge are betting that bonuses and better work accommodations will finally be enough to attract and keep the mental health providers needed to treat prisoners. The funds come from nearly $200…
Amid the challenges of adulthood, one rite of passage is unique to the United States: the need to find your own health insurance by the time you turn 26. That is the age at which the Affordable Care Act declares that young adults generally must get off their family’s plan and figure out their coverage…
Shirley Ryan AbilityLab Earns New Joint Commission Sustainability Award With support from Compass One Healthcare, Shirley Ryan AbilityLab has reached another milestone in its commitment to environmental stewardship. The Chicago-based rehabilitation hospital, renowned for treating patients with stroke, spinal cord, and brain injuries, has earned The Joint Commission’s new Sustainability Healthcare Certification. It is the…
This brief provides an update on Planned Parenthood closures and participation in the Title X program in the midst of substantial policy changes leading to decreased funding for Planned Parenthood including the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.
Editas Medicine says its in vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. Editas is shifting focusing to in vivo gene-editing therapies. The post Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D appeared first on MedCity News.
[Sponsored] Whether you want an American spine clinic close to home or are willing to travel, the U.S. has numerous options. Compare leading surgical facilities to locate much-needed care without an extra wait. The post Top US Spine Clinics for Canadians: Expert Care Across the Border appeared first on MedCity News.
By prioritizing sustainability-minded and compliant waste management in the workplace, healthcare leaders can advance patient and employee well-being, as well as environmental and fiscally responsible programs. The post Advancing Patient & Planet Health Through Proper Healthcare Waste Management appeared first on MedCity News.
Yuzu’s $35 million round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom and Neo. The post TPA Yuzu Health Aims to Revamp Health Benefits with $35M Boost appeared first on MedCity News.